Clinical Trials
126 trialsTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
ArchAid-002
Beijing GoBroad Hospital
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Hadassah Medical Organization
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Hoffmann-La Roche
EGR2
Assistance Publique - Hôpitaux de Paris
UP-RISING
AbbVie
RA-DRUM
Diakonhjemmet Hospital
The Sequestration of Holistic Stress Management Techniques for Adults
Virtual Tribunal Monastery
COTIRA
University of Aarhus
GREAT1
University of Pittsburgh
Comprehensive Segmental Revision System
Zimmer Biomet
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
Bristol-Myers Squibb
DANBIO
Bristol-Myers Squibb
VITAL
Brigham and Women's Hospital
PRESAGE
Assistance Publique - Hôpitaux de Paris
Comparative Autoantibody and Immunologic Cell Marker Study
Emory University
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity
Universitätsklinikum Hamburg-Eppendorf
CareRA2020
Universitaire Ziekenhuizen KU Leuven
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer
Effect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis.
Instituto Mexicano del Seguro Social
EMPOWER
Future Genetics Limited
OTIS Humira Pregnancy Registry
University of California, San Diego
OTIS Cimzia Pregnancy Registry
University of California, San Diego
HRP
Exactech
REALISE
NHS Greater Glasgow and Clyde
Advanced Therapeutics in Rheumatoid Arthritis (RA)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
QUANTUM
VitaMed Research LLC
A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.
RemeGen Co., Ltd.
Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis
Mabscale, LLC
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
UCB Pharma
Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.
Aalborg University Hospital
Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.
Pfizer
STARA
Georgetown University
PPM:RANT
Brigham and Women's Hospital
RABEX
Rigshospitalet, Denmark
PatientSpot Formerly Known as ArthritisPower
Global Healthy Living Foundation
CREDO 4
R-Pharm
LTC
King's College London
CREDO 3
R-Pharm
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
Atara Biotherapeutics
BIORA-PAIN
St George's, University of London
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Alliance Foundation Trials, LLC.
ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis
Ionis Pharmaceuticals, Inc.
PACEinMM-QC
Université de Sherbrooke
Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease
Peking University Third Hospital
YISTAR
Peking Union Medical College Hospital
Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis
Sohag University